Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2. O'Leary PC, Chen H, Doruk YU, Williamson T, et al. Cancer Res 2022;82:3950-3961.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

O'Leary PC, Chen H, Doruk YU, Williamson T, et al. Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2. Cancer Res 2022;82:3950-3961.
PMID: 36273492